Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
Toni Celià-Terrassa, … , Pedro L. Fernández, Timothy M. Thomson
Toni Celià-Terrassa, … , Pedro L. Fernández, Timothy M. Thomson
Published April 16, 2012
Citation Information: J Clin Invest. 2012;122(5):1849-1868. https://doi.org/10.1172/JCI59218.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 13

Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells

  • Text
  • PDF
Abstract

Malignant progression in cancer requires populations of tumor-initiating cells (TICs) endowed with unlimited self renewal, survival under stress, and establishment of distant metastases. Additionally, the acquisition of invasive properties driven by epithelial-mesenchymal transition (EMT) is critical for the evolution of neoplastic cells into fully metastatic populations. Here, we characterize 2 human cellular models derived from prostate and bladder cancer cell lines to better understand the relationship between TIC and EMT programs in local invasiveness and distant metastasis. The model tumor subpopulations that expressed a strong epithelial gene program were enriched in highly metastatic TICs, while a second subpopulation with stable mesenchymal traits was impoverished in TICs. Constitutive overexpression of the transcription factor Snai1 in the epithelial/TIC-enriched populations engaged a mesenchymal gene program and suppressed their self renewal and metastatic phenotypes. Conversely, knockdown of EMT factors in the mesenchymal-like prostate cancer cell subpopulation caused a gain in epithelial features and properties of TICs. Both tumor cell subpopulations cooperated so that the nonmetastatic mesenchymal-like prostate cancer subpopulation enhanced the in vitro invasiveness of the metastatic epithelial subpopulation and, in vivo, promoted the escape of the latter from primary implantation sites and accelerated their metastatic colonization. Our models provide new insights into how dynamic interactions among epithelial, self-renewal, and mesenchymal gene programs determine the plasticity of epithelial TICs.

Authors

Toni Celià-Terrassa, Óscar Meca-Cortés, Francesca Mateo, Alexia Martínez de Paz, Nuria Rubio, Anna Arnal-Estapé, Brian J. Ell, Raquel Bermudo, Alba Díaz, Marta Guerra-Rebollo, Juan José Lozano, Conchi Estarás, Catalina Ulloa, Daniel ρlvarez-Simón, Jordi Milà, Ramón Vilella, Rosanna Paciucci, Marian Martínez-Balbás, Antonio García de Herreros, Roger R. Gomis, Yibin Kang, Jerónimo Blanco, Pedro L. Fernández, Timothy M. Thomson

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2009 Total
Citations: 3 10 13 15 14 23 22 23 33 24 30 25 24 10 1 270
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (270)

Title and authors Publication Year
Long Non-Coding RNAs: Key Regulators of Tumor Epithelial/Mesenchymal Plasticity and Cancer Stemness
Yuan Y, Tang Y, Fang Z, Wen J, Wicha MS, Luo M
Cells 2025
Omics Investigations of Prostate Cancer Cells Exposed to Simulated Microgravity Conditions
Schulz H, Abdelfattah F, Heinrich A, Melnik D, Sandt V, Krüger M, Wehland M, Hoffmann P, Cortés-Sánchez JL, Evert M, Evert K, Grimm D
Biomolecules 2025
Organoids technology in cancer research: from basic applications to advanced ex vivo models
Varinelli L, Illescas O, Lorenc EJ, Battistessa D, Di Bella M, Zanutto S, Gariboldi M
Frontiers in Cell and Developmental Biology 2025
How important is EMT for cancer metastasis?
Celià-Terrassa T, Kang Y
PLoS Biology 2024
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Hu J, Liu K, Ghosh C, Khaket TP, Shih H, Kebebew E
Journal of experimental & clinical cancer research : CR 2024
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
BharathwajChetty B, Sajeev A, Vishwa R, Aswani BS, Alqahtani MS, Abbas M, Kunnumakkara AB
Cancer metastasis reviews 2024
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1
Dillen A, Bui I, Jung M, Agioti S, Zaravinos A, Bonavida B
Cancers 2024
Data- and theory-driven approaches for understanding paths of epithelial-mesenchymal transition.
Hong T, Xing J
Genesis (New York, N.Y. : 2000) 2024
Cancer spreading patterns based on epithelial-mesenchymal plasticity.
Wang R, Yan Z
Frontiers in Cell and Developmental Biology 2024
Cell-intrinsic and microenvironmental determinants of metastatic colonization.
Lambert AW, Zhang Y, Weinberg RA
Nature Cell Biology 2024
Phenotypic Plasticity and Cancer: A System Biology Perspective
Subbalakshmi AR, Ramisetty S, Mohanty A, Pareek S, Do D, Shrestha S, Khan A, Talwar N, Tan T, Vishnubhotla P, Singhal SS, Salgia R, Kulkarni P
Journal of Clinical Medicine 2024
The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotype
Herndon ME, Ayers M, Gibson-Corley KN, Wendt MK, Wallrath LL, Henry MD, Stipp CS
Disease Models & Mechanisms 2024
Intricate relationship between cancer stemness, metastasis, and drug resistance
Dakal TC, Bhushan R, Xu C, Gadi BR, Cameotra SS, Yadav V, Maciaczyk J, Schmidt\u2010Wolf IG, Kumar A, Sharma A
MedComm 2024
Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma.
Tunuguntla A, Suresh TN, Pn S
Cureus 2023
EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?
Akhmetkaliyev A, Alibrahim N, Shafiee D, Tulchinsky E
Molecular Cancer 2023
The paradox of cooperation among selfish cancer cells.
Capp JP, Thomas F, Marusyk A, M Dujon A, Tissot S, Gatenby R, Roche B, Ujvari B, DeGregori J, Brown JS, Nedelcu AM
Evolutionary Applications 2023
Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review
Zhao X, Wang Y, Xia H, Liu S, Huang Z, He R, Yu L, Meng N, Wang H, You J, Li J, Yam JW, Xu Y, Cui Y
Journal of Clinical and Translational Hepatology 2023
Cancer Stem Cells and Their Therapeutic Usage.
Osum M, Kalkan R
Advances in experimental medicine and biology 2023
Active compounds of Caodoukou (Semen Alpinia Katsumadai) inhibit the migration, invasion and metastasis of human pancreatic cancer cells by targeting phosphoinosmde-3-kinase/ protein kinase B/mammalian target of rapamycin pathway
YANG X, WANG J, CHENG L, ZHANG Y, HUANG J, LIU M
Journal of Traditional Chinese Medicine 2023
Therapeutic vulnerabilities of cancer stem cells and effects of natural products
Reisenauer KN, Aroujo J, Tao Y, Ranganathan S, Romo D, Taube JH
Natural Product Reports 2023
Oncostatin-M and OSM-Receptor feed-forward activation of MAPK induces separable stem-like and mesenchymal programs
Polak KL, Tamagno I, Parameswaran N, Smigiel J, Chan ER, Yuan X, Rios B, Jackson MW
Molecular cancer research : MCR 2023
The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer
Hodgson K, Orozco-Moreno M, Scott E, Garnham R, Livermore K, Thomas H, Zhou Y, He J, Bermudez A, Garcia Marques FJ, Bastian K, Hysenaj G, Archer Goode E, Heer R, Pitteri S, Wang N, Elliott DJ, Munkley J
Scientific Reports 2023
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zeng Z, Fu M, Hu Y, Wei Y, Wei X, Luo M
Molecular Cancer 2023
Reactivation of embryonic genetic programs in tissue regeneration and disease.
Fazilaty H, Basler K
Nature Genetics 2023
Role of epithelial splicing regulatory protein 1 in cancer progression
Kwon MJ
Cancer Cell International 2023
Update on Epithelial-Mesenchymal Plasticity in Cancer Progression
Fontana R, Mestre-Farrera A, Yang J
Annual review of pathology 2023
LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells
B Fan, Q Zhang, N Wang, G Wang
Frontiers in Oncology 2022
Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis
M Primeaux, S Gowrikumar, P Dhawan
Clinical & Experimental Metastasis 2022
Interconnected high-dimensional landscapes of epithelial–mesenchymal plasticity and stemness in cancer
S Sahoo, B Ashraf, A Duddu, A Biddle, M Jolly
Clinical & Experimental Metastasis 2022
Canonical TGFβ signaling induces collective invasion in colorectal carcinogenesis through a Snail1- and Zeb1-independent partial EMT
M Flum, S Dicks, Y Teng, M Schrempp, A Nyström, M Boerries, A Hecht
Oncogene 2022
Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?
M Migault, S Sapkota, C Bracken
Cellular and Molecular Life Sciences 2022
Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
Pal AK, Sharma P, Zia A, Siwan D, Nandave D, Nandave M, Gautam RK
Pathophysiology 2022
Conflicting Roles of ZFP36L1 in Regulating the Progression of Muscle Invasive Bladder Cancer.
Yuan S, Zhai Y, Tao T, Zhang X, Bashir G, Li G, Wang G, Wu S
Frontiers in Molecular Biosciences 2022
Circulating tumor cells in the early detection of human cancers
Feng Z, Wu J, Lu Y, Chan YT, Zhang C, Wang D, Luo D, Huang Y, Feng Y, Wang N
International journal of biological sciences 2022
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim SK, Cho SW
Frontiers in pharmacology 2022
Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review
Orrapin S, Udomruk S, Lapisatepun W, Moonmuang S, Phanphaisarn A, Phinyo P, Pruksakorn D, Chaiyawat P
Cancers 2022
Insights into Circulating Tumor Cell Clusters: A Barometer for Treatment Effects and Prognosis for Prostate Cancer Patients
Lu L, Hu W, Liu B, Yang T
Cancers 2022
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.
Huang Y, Hong W, Wei X
Journal of Hematology & Oncology 2022
Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancer.
Lee CL, Chang YH, Liu CY, Hsieh ML, Huang LK, Chu YC, Kan HC, Lin PH, Yu KJ, Chuang CK, Wu CT, Pang ST, Shao IH
Investigative and Clinical Urology 2022
Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
Castellón EA, Indo S, Contreras HR
International journal of molecular sciences 2022
ΔNp63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells.
Lambert AW, Fiore C, Chutake Y, Verhaar ER, Strasser PC, Chen MW, Farouq D, Das S, Li X, Eaton EN, Zhang Y, Liu Donaher J, Engstrom I, Reinhardt F, Yuan B, Gupta S, Wollison B, Eaton M, Bierie B, Carulli J, Olson ER, Guenther MG, Weinberg RA
Developmental Cell 2022
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
S Saxena, RK Singh
Cancer and Metastasis Reviews 2021
Epithelial to Mesenchymal Transition History: From Embryonic Development to Cancers
C Lachat, P Peixoto, E Hervouet
Biomolecules 2021
The gate to metastasis: key players in cancer cell intravasation
MK Sznurkowska, N Aceto
The FEBS journal 2021
Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States
L Bornes, G Belthier, J van Rheenen
Journal of Clinical Medicine 2021
Linking EMT programmes to normal and neoplastic epithelial stem cells
AW Lambert, RA Weinberg
Nature Reviews Cancer 2021
Communication Between Epithelial–Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression
X Zheng, F Dai, L Feng, H Zou, L Feng, M Xu
Frontiers in Oncology 2021
Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach
H Shen, Y Chen, Y Wan, T Liu, J Wang, Y Zhang, L Wei, Q Hu, B Xu, M Chernov, C Frangou, J Zhang
Frontiers in Cell and Developmental Biology 2021
Partial EMT in head and neck cancer biology: a spectrum instead of a switch
A Pal, TF Barrett, R Paolini, A Parikh, SV Puram
Oncogene 2021
The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
K Patil, FB Khan, S Akhtar, A Ahmad, S Uddin
Cancer and Metastasis Reviews 2021
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation
NR Campbell, A Rao, MV Hunter, MK Sznurkowska, L Briker, M Zhang, M Baron, S Heilmann, M Deforet, C Kenny, LP Ferretti, TH Huang, S Perlee, M Garg, J Nsengimana, M Saini, E Montal, M Tagore, J Newton-Bishop, MR Middleton, P Corrie, DJ Adams, R Rabbie, N Aceto, MP Levesque, RA Cornell, I Yanai, JB Xavier, RM White
Developmental Cell 2021
Partial EMT in Squamous Cell Carcinoma: A Snapshot
C Liao, Q Wang, J An, Q Long, H Wang, M Xiang, M Xiang, Y Zhao, Y Liu, J Liu, X Guan
International journal of biological sciences 2021
Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
S Sahoo, SP Nayak, K Hari, P Purkait, S Mandal, A Kishore, H Levine, MK Jolly
Frontiers in immunology 2021
Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer
L Long, Y Hu, T Long, X Lu, Y Tuo, Y Li, Z Ke
Journal for ImmunoTherapy of Cancer 2021
Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks
S Uhan, N Hauptman
Cells 2021
New Insights into Therapy-Induced Progression of Cancer
PV Shnaider, OM Ivanova, IK Malyants, KS Anufrieva, IA Semenov, MS Pavlyukov, MA Lagarkova, VM Govorun, VO Shender
International journal of molecular sciences 2020
ΔNp63-Regulated Epithelial-to-Mesenchymal Transition State Heterogeneity Confers a Leader–Follower Relationship That Drives Collective Invasion
JM Westcott, S Camacho, A Nasir, ME Huysman, R Rahhal, TT Dang, AT Riegel, RA Brekken, GW Pearson
Cancer research 2020
LTBP1 plays a potential bridge between depressive disorder and glioblastoma
X Fu, P Zhang, H Song, C Wu, S Li, S Li, C Yan
Journal of Translational Medicine 2020
EMT Factors and Metabolic Pathways in Cancer
I Georgakopoulos-Soares, DV Chartoumpekis, V Kyriazopoulou, A Zaravinos
Frontiers in Oncology 2020
Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
JP Vernot
Frontiers in Molecular Biosciences 2020
Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells
L Chen, MB Olszewski, MK Julio, BE Snaar-Jagalska
Cells 2020
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
M Carceles-Cordon, WK Kelly, L Gomella, KE Knudsen, V Rodriguez-Bravo, J Domingo-Domenech
Nature Reviews Urology 2020
Direct and Indirect Regulators of Epithelial–Mesenchymal Transition–Mediated Immunosuppression in Breast Carcinomas
A Dongre, M Rashidian, EN Eaton, F Reinhardt, P Thiru, M Zagorulya, S Nepal, T Banaz, A Martner, S Spranger, RA Weinberg
Cancer Discovery 2020
Tracking cancer progression: from circulating tumor cells to metastasis
F Castro-Giner, N Aceto
Genome Medicine 2020
Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
TJ Mathias, KT Chang, SS Martin, MI Vitolo
Cancers 2020
Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms
TT Liao, MH Yang
Cells 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
JJ Alumkal, D Sun, E Lu, TM Beer, GV Thomas, E Latour, R Aggarwal, J Cetnar, CJ Ryan, S Tabatabaei, S Bailey, CB Turina, DA Quigley, X Guan, A Foye, JF Youngren, J Urrutia, J Huang, AS Weinstein, V Friedl, M Rettig, RE Reiter, DE Spratt, M Gleave, CP Evans, JM Stuart, Y Chen, FY Feng, EJ Small, ON Witte, Z Xia
Proceedings of the National Academy of Sciences 2020
EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
A Genna, AM Vanwynsberghe, AV Villard, C Pottier, J Ancel, M Polette, C Gilles
Cancers 2020
Dynamics of Cellular Plasticity in Prostate Cancer Progression
R Tiwari, N Manzar, B Ateeq
Frontiers in Molecular Biosciences 2020
Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT
W Jia, S Tripathi, P Chakraborty, A Chedere, A Rangarajan, H Levine, MK Jolly
Oncotarget 2020
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
C Koch, A Kuske, SA Joosse, G Yigit, G Sflomos, S Thaler, DJ Smit, S Werner, K Borgmann, S Gärtner, PM Mohammadi, L Battista, L Cayrefourcq, J Altmüller, G SalinasRiester, K Raithatha, A Zibat, Y Goy, L Ott, K Bartkowiak, TZ Tan, Q Zhou, MR Speicher, V Müller, TM Gorges, M Jücker, JP Thiery, C Brisken, S Riethdorf, C AlixPanabières, K Pantel
EMBO Molecular Medicine 2020
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
K Saxena, MK Jolly, K Balamurugan
Translational oncology 2020
Cyanidin-3-O-glucoside inhibits epithelial-to-mesenchymal transition, and migration and invasion of breast cancer cells by upregulating KLF4
D Chen, M Yuan, Q Ye, X Wang, J Xu, G Shi, Z Hu
Food & Nutrition Research 2020
Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression
D Sinha, P Saha, A Samanta, A Bishayee
Biomolecules 2020
Angiotensin Inhibition, TGF-β and EMT in Cancer
FB Pallasch, U Schumacher
Cancers 2020
Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology
S Pasani, S Sahoo, MK Jolly
Journal of Clinical Medicine 2020
Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients
X Dong, Y Ma, X Zhao, X Tian, Y Sun, Y Yang, X Zhao
Annals of translational medicine 2020
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.
Celià-Terrassa T, Jolly MK
Cold Spring Harbor Perspectives in Medicine 2020
Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Epithelial–Mesenchymal Transition
S Kletukhina, O Neustroeva, V James, A Rizvanov, M Gomzikova
International journal of molecular sciences 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
YZ Mazzu, J Armenia, G Chakraborty, Y Yoshikawa, SA Coggins, S Nandakumar, TA Gerke, MM Pomerantz, X Qiu, H Zhao, M Atiq, N Khan, K Komura, GS Lee, SW Fine, C Bell, E O'Connor, HW Long, ML Freedman, B Kim, PW Kantoff
Clinical cancer research 2019
Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis
M Esposito, N Mondal, TM Greco, Y Wei, C Spadazzi, SC Lin, H Zheng, C Cheung, JL Magnani, SH Lin, IM Cristea, R Sackstein, Y Kang
Nature Cell Biology 2019
Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma
S Laudato, A Aparicio, FG Giancotti
Trends in Cancer 2019
Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
F Fontana, M Raimondi, M Marzagalli, M Sommariva, P Limonta, N Gagliano
Cells 2019
Metabolic Plasticity and Epithelial-Mesenchymal Transition
TM Thomson, C Balcells, M Cascante
Journal of Clinical Medicine 2019
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
W Lu, Y Kang
Developmental Cell 2019
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
A Siddiqui, PN Gollavilli, A Schwab, ME Vazakidou, PG Ersan, M Ramakrishnan, D Pluim, SA Coggins, O Saatci, L Annaratone, JH Schellens, B Kim, IA Asangani, SA Rasheed, C Marchiò, O Sahin, P Ceppi
Cell Death and Differentiation 2019
A Mathematical Framework for Modelling the Metastatic Spread of Cancer
LC Franssen, T Lorenzi, AE Burgess, MA Chaplain
Bulletin of Mathematical Biology 2019
Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response
D Jia, X Li, F Bocci, S Tripathi, Y Deng, MK Jolly, JN Onuchic, H Levine
Journal of Clinical Medicine 2019
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
C Kröger, A Afeyan, J Mraz, EN Eaton, F Reinhardt, YL Khodor, P Thiru, B Bierie, X Ye, CB Burge, RA Weinberg
Proceedings of the National Academy of Sciences 2019
Contribution of Epithelial Plasticity to Therapy Resistance
PG Santamaría, G Moreno-Bueno, A Cano
Journal of Clinical Medicine 2019
Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
GW Pearson
Journal of Clinical Medicine 2019
Breast Cancer Stem Cells with Tumor- versus Metastasis-Initiating Capacities Are Modulated by TGFBR1 Inhibition
F Fico, M Bousquenaud, C Rüegg, A Santamaria-Martínez
Stem Cell Reports 2019
Cancer Stem Cells and Radioresistance: DNA Repair and Beyond
A Schulz, F Meyer, A Dubrovska, K Borgmann
Cancers 2019
FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E‐cadherin and CD44 expression
Y Hong, H Qin, Y Li, Y Zhang, X Zhuang, L Liu, K Lu, L Li, X Deng, F Liu, S Shi, G Liu
Journal of Cellular Physiology 2019
A gene regulatory network to control EMT programs in development and disease
H Fazilaty, L Rago, KK Youssef, OH Ocaña, F Garcia-Asencio, A Arcas, J Galceran, MA Nieto
Nature Communications 2019
Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression
MK Jolly, T Celià-Terrassa
Journal of Clinical Medicine 2019
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
ED Williams, D Gao, A Redfern, EW Thompson
Nature Reviews Cancer 2019
Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells
S Beyes, G Andrieux, M Schrempp, D Aicher, J Wenzel, P Antón-García, M Boerries, A Hecht
Oncogene 2019
Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma
Z Pan, J Lin, D Wu, X He, W Wang, X Hu, L Zhang, M Wang
Aging 2019
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.
Dongre A, Weinberg RA
Nature reviews. Molecular cell biology 2019
Concise Review: Prostate Cancer Stem Cells: Current Understanding: Prostate Cancer Stem Cells
S Skvortsov, II Skvortsova, DG Tang, A Dubrovska
Stem Cells 2018
A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome
N Stylianou, ML Lehman, C Wang, AT Fard, A Rockstroh, L Fazli, L Jovanovic, M Ward, MC Sadowski, AS Kashyap, R Buttyan, ME Gleave, TF Westbrook, ED Williams, JH Gunter, CC Nelson, BG Hollier
Oncogene 2018
Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4
J Bellmunt
Biomedicines 2018
A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling
F Bocci, MK Jolly, JT George, H Levine, JN Onuchic
Oncotarget 2018
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
AD Redfern, LJ Spalding, EW Thompson
Clinical & Experimental Metastasis 2018
Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells
P Gener, J Seras-Franzoso, PG Callejo, F Andrade, D Rafael, F Martínez, S Montero, D Arango, J Sayós, I Abasolo, S Schwartz
Stem Cells International 2018
Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells
KB Nayak, IS Sajitha, TR Kumar, S Chakraborty
Cell Death and Disease 2018
EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
K Weidenfeld, D Barkan
Frontiers in Oncology 2018
Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization
CC Lee, JC Lin, WL Hwang, YJ Kuo, HK Chen, SK Tai, CC Lin, MH Yang
Nature Communications 2018
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
AH Davies, H Beltran, A Zoubeidi
Nature Reviews Urology 2018
Metastatic niche functions and therapeutic opportunities
T Celià-Terrassa, Y Kang
Nature Cell Biology 2018
Mammary Stem Cells and Breast Cancer Stem Cells: Molecular Connections and Clinical Implications
T Celià-Terrassa
Biomedicines 2018
Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells
IM de Mas, E Aguilar, E Zodda, C Balcells, S Marin, G Dallmann, TM Thomson, B Papp, M Cascante, NE Lewis
PLoS computational biology 2018
Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells
AM Mon, AC MacKinnon, P Traktman, A Ahmad
PloS one 2018
Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations
A Jayaraman, P Kumar, S Marin, P de Atauri, F Mateo, TM Thomson, JJ Centelles, SF Graham, M Cascante, D Nie
PloS one 2018
A SIRT1-centered circuitry regulates breast cancer stemness and metastasis
L Shi, X Tang, M Qian, Z Liu, F Meng, L Fu, Z Wang, WG Zhu, JD Huang, Z Zhou, B Liu
Oncogene 2018
Loss of inter-cellular cooperation by complete epithelial-mesenchymal transition supports favorable outcomes in basal breast cancer patients
A Grosse-Wilde, RE Kuestner, SM Skelton, E MacIntosh, AF dHérouël, G Ertaylan, A del Sol, A Skupin, S Huang
Oncotarget 2018
Role of miR‑23a/Zeb1 negative feedback loop in regulating epithelial‑mesenchymal transition and tumorigenicity of intraocular tumors
Y Wang, Y Luo, W Guan, H Zhao
Oncology Letters 2018
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma
XK Qi, HQ Han, HJ Zhang, M Xu, L Li, L Chen, T Xiang, QS Feng, T Kang, CN Qian, MY Cai, Q Tao, YX Zeng, L Feng
Theranostics 2018
Epithelial plasticity in cancer: beyond metastasis
TM Thomson, PL Fernández
Aging 2018
Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
X Yang, X Liang, M Zheng, Y Tang
Frontiers in Oncology 2018
Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability
T Celià-Terrassa, C Bastian, D Liu, B Ell, NM Aiello, Y Wei, J Zamalloa, AM Blanco, X Hang, D Kunisky, W Li, ED Williams, H Rabitz, Y Kang
Nature Communications 2018
CD24 expression and stem-associated features define tumor cell heterogeneity and tumorigenic capacities in a model of carcinogenesis
P Ortiz-Montero, WY Liu-Bordes, A Londoño-Vallejo, JP Vernot
Cancer management and research 2018
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells
L Sánchez-Cid, M Pons, JJ Lozano, N Rubio, M Guerra-Rebollo, A Soriano, L Paris-Coderch, MF Segura, R Fueyo, J Arguimbau, E Zodda, R Bermudo, I Alonso, X Caparrós, M Cascante, A Rafii, Y Kang, M Martínez-Balbás, SJ Weiss, J Blanco, M Muñoz, PL Fernández, TM Thomson
Oncotarget 2017
The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells
F Marcucci, P Ghezzi, C Rumio
Molecular Cancer 2017
Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells
CH Hsieh, SC Hsiung, CT Yeh, CF Yen, YH Chou, WY Lei, ST Pang, CK Chuang, SK Liao
Oncotarget 2017
Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites
C Melzer, J der Ohe, R Hass
BioMed Research International 2017
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
SY Lee, EK Jeong, MK Ju, HM Jeon, MY Kim, CH Kim, HG Park, SI Han, HS Kang
Molecular Cancer 2017
A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics
N Harner-Foreman, J Vadakekolathu, SA Laversin, MG Mathieu, S Reeder, AG Pockley, RC Rees, DJ Boocock
Scientific Reports 2017
EMT: Present and future in clinical oncology
PG Santamaria, G Moreno-Bueno, F Portillo, A Cano
Molecular Oncology 2017
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner
R Sheta, ZQ Wang, M Bachvarova, M Plante, J Gregoire, MC Renaud, A Sebastianelli, S Gobeil, C Morin, E Macdonald, B Vanderhyden, D Bachvarov
Oncotarget 2017
Epithelial-to-mesenchymal transition in tumor progression
E Prieto-García, CV Díaz-García, I García-Ruiz, MT Agulló-Ortuño
Medical Oncology 2017
Tumor cell dormancy
RR Gomis, S Gawrzak
Molecular Oncology 2017
Emerging Biological Principles of Metastasis
AW Lambert, DR Pattabiraman, RA Weinberg
Cell 2017
Cellular determinants and microenvironmental regulation of prostate cancer metastasis
K Rycaj, H Li, J Zhou, X Chen, DG Tang
Seminars in Cancer Biology 2017
EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
D Pradella, C Naro, C Sette, C Ghigna
Molecular Cancer 2017
ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells
HM Jeong, J Han, SH Lee, HJ Park, HJ Lee, JS Choi, YM Lee, YL Choi, YK Shin, MJ Kwon
Oncogenesis 2017
Distinguishing mechanisms underlying EMT tristability
D Jia, MK Jolly, SC Tripathi, PD Hollander, B Huang, M Lu, M Celiktas, E Ramirez-Peña, E Ben-Jacob, JN Onuchic, SM Hanash, SA Mani, H Levine
Cancer Convergence 2017
Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a–LCOR axis
T Celià-Terrassa, DD Liu, A Choudhury, X Hang, Y Wei, J Zamalloa, R Alfaro-Aco, R Chakrabarti, YZ Jiang, BI Koh, HA Smith, C DeCoste, JJ Li, ZM Shao, Y Kang
Nature Cell Biology 2017
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells
A Faddaoui, R Sheta, M Bachvarova, M Plante, J Gregoire, MC Renaud, A Sebastianelli, S Gobeil, C Morin, K Ghani, D Bachvarov
Cell cycle (Georgetown, Tex.) 2017
Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study
L Pereira, P Silva, M Duarte, L Rodrigues, C Duarte, C Albuquerque, A Serra
Nutrients 2017
EMT and MET: necessary or permissive for metastasis?
MK Jolly, KE Ware, S Gilja, JA Somarelli, H Levine
Molecular Oncology 2017
Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
MK Jolly, SC Tripathi, JA Somarelli, SM Hanash, H Levine
Molecular Oncology 2017
Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
TT Liao, MH Yang
Molecular Oncology 2017
Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory
D Jia, MK Jolly, P Kulkarni, H Levine
Cancers 2017
Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin
HJ Hugo, NP Gunasinghe, BG Hollier, T Tanaka, T Blick, A Toh, P Hill, C Gilles, M Waltham, EW Thompson
Breast Cancer Research 2017
Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
M Singh, D Bakhshinyan, C Venugopal, SK Singh
Frontiers in Oncology 2017
Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression
H Nishino, S Takano, H Yoshitomi, K Suzuki, S Kagawa, R Shimazaki, H Shimizu, K Furukawa, M Miyazaki, M Ohtsuka
Cancer Medicine 2017
Network analysis of EMT and MET micro-RNA regulation in breast cancer
D Drago-García, J Espinal-Enríquez, E Hernández-Lemus
Scientific Reports 2017
Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer
K Suzuki, S Takano, H Yoshitomi, H Nishino, S Kagawa, H Shimizu, K Furukawa, M Miyazaki, M Ohtsuka
Oncotarget 2017
Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response
WW Sun, ZH Xu, P Lian, BL Gao, JA Hu
OncoTargets and therapy 2017
Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
J Zhao, J Li, TW Fan, SX Hou
Oncotarget 2017
Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric
JT George, MK Jolly, S Xu, JA Somarelli, H Levine
Cancer research 2017
Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma
M Natsuizaka, KA Whelan, S Kagawa, K Tanaka, V Giroux, PM Chandramouleeswaran, A Long, V Sahu, DS Darling, J Que, Y Yang, JP Katz, EP Wileyto, D Basu, Y Kita, S Natsugoe, S Naganuma, AJ Klein-Szanto, JA Diehl, AJ Bass, KK Wong, AK Rustgi, H Nakagawa
Nature Communications 2017
Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review
S Wang, S Huang, YL Sun
BioMed Research International 2017
Cancer stem cells revisited
E Batlle, H Clevers
Nature Medicine 2017
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization
S Takano, M Reichert, B Bakir, KK Das, T Nishida, M Miyazaki, S Heeg, MA Collins, B Marchand, PD Hicks, A Maitra, AK Rustgi
Genes & development 2016
Distinctive properties of metastasis-initiating cells
T Celià-Terrassa, Y Kang
Genes & development 2016
The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states
MJ Toneff, A Sreekumar, A Tinnirello, PD Hollander, S Habib, S Li, MJ Ellis, L Xin, SA Mani, JM Rosen
BMC Biology 2016
The histone variant H2A.X is a regulator of the epithelial–mesenchymal transition
U Weyemi, CE Redon, R Choudhuri, T Aziz, D Maeda, M Boufraqech, PR Parekh, TK Sethi, M Kasoji, N Abrams, A Merchant, VN Rajapakse, WM Bonner
Nature Communications 2016
Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells
W Chen, JK Yi, T Shimane, S Mehrazarin, YL Lin, KH Shin, RH Kim, NH Park, MK Kang
Carcinogenesis 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer
LA Selth, R Das, SL Townley, I Coutinho, AR Hanson, MM Centenera, N Stylianou, K Sweeney, C Soekmadji, L Jovanovic, CC Nelson, A Zoubeidi, LM Butler, GJ Goodall, BG Hollier, PA Gregory, WD Tilley
Oncogene 2016
Senescence from glioma stem cell differentiation promotes tumor growth
R Ouchi, S Okabe, T Migita, I Nakano, H Seimiya
Biochemical and Biophysical Research Communications 2016
Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program: Cancer Stem Cell Metabolism Uncoupled From Epithelial-Mesenchymal Transition
E Aguilar, IM de Mas, E Zodda, S Marin, F Morrish, V Selivanov, Ó Meca-Cortés, H Delowar, M Pons, I Izquierdo, T Celià-Terrassa, P Atauri, JJ Centelles, D Hockenbery, TM Thomson, M Cascante
Stem Cells 2016
Clonal cooperativity in heterogenous cancers
H Zhou, D Neelakantan, HL Ford
Seminars in Cell & Developmental Biology 2016
Probing the Fifty Shades of EMT in Metastasis
W Li, Y Kang
Trends in Cancer 2016
New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
I Fabregat, A Malfettone, J Soukupova
Journal of Clinical Medicine 2016
Loss of N-Cadherin Expression in Tumor Transplants Produced From As+3- and Cd+2-Transformed Human Urothelial (UROtsa) Cell Lines
EJ Sandquist, S Somji, JR Dunlevy, SH Garrett, XD Zhou, A Slusser-Nore, DA Sens, RA Winn
PloS one 2016
CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis
J Oba, T Nakahara, A Hashimoto-Hachiya, M Liu, T Abe, A Hagihara, T Yokomizo, M Furue, SS Dadras
PloS one 2016
Epithelial-mesenchymal transition in tumor metastasis
KT Yeung, J Yang
Molecular Oncology 2016
Linking Pluripotency Reprogramming and Cancer: Linking Pluripotency Reprogramming and Cancer
JM Iglesias, J Gumuzio, AG Martin
Stem Cells Translational Medicine 2016
Targeting metastasis-initiating cells through the fatty acid receptor CD36
G Pascual, A Avgustinova, S Mejetta, M Martín, A Castellanos, CS Attolini, A Berenguer, N Prats, A Toll, JA Hueto, C Bescós, LD Croce, SA Benitah
Nature 2016
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy
DR Pattabiraman, RA Weinberg
Cold Spring Harbor Symposia on Quantitative Biology 2016
A key role for transketolase-like 1 in tumor metabolic reprogramming
S Diaz-Moralli, E Aguilar, S Marin, JF Coy, M Dewerchin, MR Antoniewicz, O Meca-Cortés, L Notebaert, B Ghesquière, G Eelen, TM Thomson, P Carmeliet, M Cascante
Oncotarget 2016
Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells
AJ Gooding, WP Schiemann
Translational cancer research 2016
In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3
M Botlagunta, B Kollapalli, L Kakarla, SP Gajarla, SP Gade, CL Dadi, A Penumadu, S Javeed
Bioinformation 2016
E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells
K Palen, J Weber, MB Dwinell, BD Johnson, R Ramchandran, JA Gershan
Oncotarget 2016
Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics
D Vergara, P Simeone, J Franck, M Trerotola, A Giudetti, L Capobianco, A Tinelli, C Bellomo, I Fournier, A Gaballo, S Alberti, M Salzet, M Maffia
EuPA Open Proteomics 2016
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells
Faddaoui A, Bachvarova M, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Gobeil S, Morin C, Macdonald E, Vanderhyden B, Bachvarov D
Oncotarget 2016
Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA, Andahur EI, Valenzuela R, Castellón EA, Fullá JA, Ramos CG, Triviño JC
Oncotarget 2016
An epigenetically distinct breast cancer cell subpopulation promotes collective invasion
Jill Westcott, Amanda Prechtl, Erin Maine, Tuyen Dang, Matt Esparza, Han Sun, Yunyun Zhou, Yang Xie, Gray Pearson
Journal of Clinical Investigation 2015
Lineage factors and differentiation states in lung cancer progression
WK Cheung, DX Nguyen
Oncogene 2015
TWIST1-induced microRNA-424 reversibly drives mesenchymal programming while inhibiting tumor initiation
DJ Drasin, AL Guarnieri, D Neelakantan, J Kim, JH Cabrera, CA Wang, V Zaberezhnyy, P Gasparini, L Cascione, K Huebner, AC Tan, HL Ford
Cancer research 2015
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
MK Jolly
Frontiers in Oncology 2015
Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications
Q Deng, DG Tang
Endocrine Related Cancer 2015
The role of EMT and MET in cancer dissemination
J Banyard, DR Bielenberg
Connective Tissue Research 2015
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis
W Iqbal, S Alkarim, A AlHejin, H Mukhtar, KS Saini
Oncotarget 2015
Control of cancer formation by intrinsic genetic noise and microenvironmental cues
A Brock, S Krause, DE Ingber
Nature Reviews Cancer 2015
Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancer
S Chen, D Zhang
FEBS Open Bio 2015
Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial–Mesenchymal Plasticity
LM McInnes, N Jacobson, A Redfern, A Dowling, EW Thompson, CM Saunders
Frontiers in Oncology 2015
ABCG2 Localizes to the Nucleus and Modulates CDH1 Expression in Lung Cancer Cells
SC Liang, CY Yang, JY Tseng, HL Wang, CY Tung, HW Liu, CY Chen, YC Yeh, TY Chou, MH Yang, J Whang-Peng, CH Lin
Neoplasia (New York, N.Y.) 2015
Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer
SK Samal, S Routray, GK Veeramachaneni, R Dash, M Botlagunta
Scientific Reports 2015
A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome
R Soundararajan, AN Paranjape, V Barsan, JT Chang, SA Mani
Scientific Reports 2015
Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival
A Grosse-Wilde, AF d’Hérouël, E McIntosh, G Ertaylan, A Skupin, RE Kuestner, A Sol, KA Walters, S Huang, E Ben-Jacob
PloS one 2015
Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study
T Ipekci, F Ozden, B Unal, C Saygin, D Uzunaslan, E Ates
Pathology & Oncology Research 2015
Cellular Plasticity in Prostate Cancer Bone Metastasis
DY Jadaan, MM Jadaan, JP McCabe
Prostate Cancer 2015
Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression
I Forno, S Ferrero, MV Russo, G Gazzano, S Giangiobbe, E Montanari, AD Nero, B Rocco, G Albo, LR Languino, DC Altieri, V Vaira, S Bosari, Z Culig
PloS one 2015
Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
M Ruscetti, B Quach, EL Dadashian, DJ Mulholland, H Wu
Cancer research 2015
Epithelial to Mesenchymal Transition in a Clinical Perspective
J Pasquier, N Abu-Kaoud, HA Thani, A Rafii
Journal of Oncology 2015
Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells
F Andriani, G Bertolini, F Facchinetti, E Baldoli, M Moro, P Casalini, R Caserini, M Milione, G Leone, G Pelosi, U Pastorino, G Sozzi, L Roz
Molecular Oncology 2015
Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition
Y Bao, Y Lu, X Wang, W Feng, X Sun, H Guo, C Tang, X Zhang, Q Shi, H Yu
Cancer Cell International 2015
The role of TWIST1 in epithelial-mesenchymal transition and cancers
QQ Zhu, C Ma, Q Wang, Y Song, T Lv
Tumor Biology 2015
When Prostate Cancer Circulates in the Bloodstream
V Vlaeminck-Guillem
Diagnostics 2015
Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
P Dong, K Ihira, J Hamada, H Watari, T Yamada, M Hosaka, SJ Hanley, M Kudo, N Sakuragi
Oncotarget 2015
Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype
AM Bleau, C Zandueta, M Redrado, S Martínez-Canarias, L Larzábal, LM Montuenga, A Calvo, F Lecanda
Oncotarget 2015
Coupling the modules of EMT and stemness: A tunable ‘stemness window’ model
MK Jolly, D Jia, M Boareto, SA Mani, KJ Pienta, E Ben-Jacob, H Levine
Oncotarget 2015
Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
Ferreira-Teixeira M, Parada B, Rodrigues-Santos P, Alves V, Ramalho JS, Caramelo F, Sousa V, Reis F, Gomes CM
Oncotarget 2015
Differentiation and transdifferentiation potentials of cancer stem cells.
Huang Z, Wu T, Liu AY, Ouyang G
Oncotarget 2015
Prostate cancer stroma: an important factor in cancer growth and progression
Krušlin B, Ulamec M, Tomas D
2015
Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
Luo M, Brooke M, Wicha MS
Current pharmaceutical design 2015
miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
D Chen, Y Sun, Y Yuan, Z Han, P Zhang, J Zhang, MJ You, J Teruya-Feldstein, M Wang, S Gupta, MC Hung, H Liang, L Ma, HL Grimes
PLoS genetics 2014
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations
F Mateo, Ó Meca-Cortés, T Celià-Terrassa, Y Fernández, I Abasolo, L Sánchez-Cid, R Bermudo, A Sagasta, L Rodríguez-Carunchio, M Pons, V Cánovas, M Marín-Aguilera, L Mengual, A Alcaraz, S Schwartz, B Mellado, KY Aguilera, R Brekken, PL Fernández, R Paciucci, TM Thomson
Molecular Cancer 2014
The extracellular matrix modulates the hallmarks of cancer
MW Pickup, JK Mouw, VM Weaver
EMBO reports 2014
FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer
AS Dhillon, E Tulchinsky
Oncogene 2014
Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
G Xie, A Ji, Q Yuan, Z Jin, Y Yuan, C Ren, Z Guo, Q Yao, K Yang, X Lin, L Chen
British Journal of Cancer 2014
Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells
S Peppicelli, F Bianchini, E Torre, L Calorini
Clinical & Experimental Metastasis 2014
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
T Oskarsson, E Batlle, J Massagué
Cell Stem Cell 2014
Tackling the cancer stem cells — what challenges do they pose?
DR Pattabiraman, RA Weinberg
Nature Reviews Drug Discovery 2014
Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis
D Neelakantan, DJ Drasin, HL Ford
Cell adhesion & migration 2014
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
RL Bitting, D Schaeffer, JA Somarelli, MA Garcia-Blanco, AJ Armstrong
Cancer and Metastasis Reviews 2014
The architect who never sleeps: Tumor-induced plasticity
J Varga, TD Oliveira, FR Greten
FEBS Letters 2014
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer
K Rönsch, S Jägle, K Rose, M Seidl, F Baumgartner, V Freihen, A Yousaf, E Metzger, S Lassmann, R Schüle, R Zeiser, T Michoel, A Hecht
Molecular Oncology 2014
Snail1-dependent control of embryonic stem cell pluripotency and lineage commitment
Y Lin, XY Li, AL Willis, C Liu, G Chen, SJ Weiss
Nature Communications 2014
Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations
BD Lopez-Ayllon, V Moncho-Amor, A Abarrategi, II de Cáceres, J Castro-Carpeño, C Belda-Iniesta, R Perona, L Sastre
Cancer Medicine 2014
Epithelial Homeostasis
IG Macara, R Guyer, G Richardson, Y Huo, SM Ahmed
Current Biology 2014
New insights into the role of ID proteins in breast cancer metastasis: a MET affair
W Teo, R Nair, A Swarbrick
Breast Cancer Research 2014
Snail1 Expression Is Required for Sarcomagenesis
L Alba-Castellón, R Batlle, C Francí, MJ Fernández-Aceñero, R Mazzolini, R Peña, J Loubat, F Alameda, R Rodríguez, J Curto, J Albanell, A Muñoz, F Bonilla, JI Casal, F Rojo, AG de Herreros
Neoplasia (New York, N.Y.) 2014
Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer
M Tania, MA Khan, J Fu
Tumor Biology 2014
SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin
G Deep, AK Jain, A Ramteke, H Ting, KC Vijendra, SC Gangar, C Agarwal, R Agarwal
Molecular Cancer 2014
Biology, detection, and clinical implications of circulating tumor cells
SA Joosse, TM Gorges, K Pantel
EMBO Molecular Medicine 2014
Epithelial-mesenchymal transition transcription factors and miRNAs: “Plastic surgeons” of breast cancer
C Moyret-Lalle
World journal of clinical oncology 2014
Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer
V Castillo, R Valenzuela, C Huidobro, H Contreras, E Castellon
International journal of oncology 2014
Brain Metastasis-Initiating Cells: Survival of the Fittest
M Singh, B Manoranjan, S Mahendram, N McFarlane, C Venugopal, S Singh
International journal of molecular sciences 2014
Cell Surface Marker Mediated Purification of iPS Cell Intermediates from a Reprogrammable Mouse Model
CM Nefzger, S Alaei, AS Knaupp, ML Holmes, JM Polo
Journal of visualized experiments : JoVE 2014
Transient SNAIL1 Expression Is Necessary for Metastatic Competence in Breast Cancer
HD Tran, K Luitel, M Kim, K Zhang, GD Longmore, DD Tran
Cancer research 2014
Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression
MC Weiger, V Vedham, CH Stuelten, K Shou, M Herrera, M Sato, W Losert, CA Parent
PloS one 2013
Identification of a cyclin d1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint
X Ju, MC Casimiro, M Gormley, H Meng, X Jiao, S Katiyar, M Crosariol, K Chen, M Wang, AA Quong, MP Lisanti, A Ertel, RG Pestell
Cancer research 2013
Epithelial-mesenchymal plasticity in carcinoma metastasis
JH Tsai, J Yang
Genes & development 2013
Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation: Triptolide Inhibits EMT and Stem-Like Features
L Liu, AV Salnikov, N Bauer, E Aleksandrowicz, S Labsch, C Nwaeburu, J Mattern, J Gladkich, P Schemmer, J Werner, I Herr
International Journal of Cancer 2013
The relevance of the TGF-β Paradox to EMT-MET programs
CD Morrison, JG Parvani, WP Schiemann
Cancer Letters 2013
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence"
M Tarabichi, A Antoniou, M Saiselet, JM Pita, G Andry, JE Dumont, V Detours, C Maenhaut
Cancer metastasis reviews 2013
Tumor metastasis: moving new biological insights into the clinic
L Wan, K Pantel, Y Kang
Nature Medicine 2013
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Y Kang, K Pantel
Cancer Cell 2013
Role of the Microenvironment in Ovarian Cancer Stem Cell Maintenance
J Pasquier, A Rafii
BioMed Research International 2013
Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells
M Kwon, Y Shin
International journal of molecular sciences 2013
Id2 Complexes with the SNAG Domain of Snai1 Inhibiting Snai1-Mediated Repression of Integrin 4
C Chang, X Yang, B Pursell, AM Mercurio
Molecular and cellular biology 2013
Cell polarity in morphogenesis and metastasis
IG Macara, L McCaffrey
Philosophical Transactions of the Royal Society B: Biological Sciences 2013
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
K Abubaker, A Latifi, R Luwor, S Nazaretian, H Zhu, MA Quinn, EW Thompson, JK Findlay, N Ahmed
Molecular Cancer 2013
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
WL Tam, H Lu, J Buikhuisen, BS Soh, E Lim, F Reinhardt, ZJ Wu, JA Krall, B Bierie, W Guo, X Chen, XS Liu, M Brown, B Lim, RA Weinberg
Cancer Cell 2013
Development of a method to isolate circulating tumor cells using mesenchymal-based capture
RL Bitting, R Boominathan, C Rao, G Kemeny, B Foulk, MA Garcia-Blanco, M Connelly, AJ Armstrong
Methods 2013
Basal/HER2 breast carcinomas: Integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)
B Martin-Castillo, C Oliveras-Ferraros, A Vazquez-Martin, S Cufí, JM Moreno, B Corominas-Faja, A Urruticoechea, ÁG Martín, E López-Bonet, JA Menendez
Cell cycle (Georgetown, Tex.) 2013
Searching for Prostate Cancer Stem Cells: Markers and Methods
B Sharpe, M Beresford, R Bowen, J Mitchard, AD Chalmers
Stem Cell Reviews and Reports 2013
ERK1/2 Blockade Prevents Epithelial-Mesenchymal Transition in Lung Cancer Cells and Promotes Their Sensitivity to EGFR Inhibition
JM Buonato, MJ Lazzara
Cancer research 2013
Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin
JM Iglesias, I Beloqui, F Garcia-Garcia, O Leis, A Vazquez-Martin, A Eguiara, S Cufi, A Pavon, JA Menendez, J Dopazo, AG Martin, N Gotoh
PloS one 2013
c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2
X Li, X Liu, W Xu, P Zhou, P Gao, S Jiang, PE Lobie, T Zhu
The Journal of biological chemistry 2013
Acid ceramidase as a therapeutic target in metastatic prostate cancer
L Camacho, O Meca-Cortes, JL Abad, S Garcia, N Rubio, A Diaz, T Celia-Terrassa, F Cingolani, R Bermudo, PL Fernandez, J Blanco, A Delgado, J Casas, G Fabrias, TM Thomson
Journal of lipid research 2013
Twist2 functions as a tumor suppressor in murine osteosarcoma cells
T Ishikawa, T Shimizu, A Ueki, SI Yamaguchi, N Onishi, E Sugihara, S Kuninaka, T Miyamoto, H Morioka, R Nakayama, E Kobayashi, Y Toyama, Y Mabuchi, Y Matsuzaki, R Yamaguchi, S Miyano, H Saya
Cancer Science 2013
The to and fro of tumour spread
BJ van Denderen, EW Thompson
Nature 2013
The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism
Chu K, Boley KM, Moraes R, Barsky SH, Robertson FM
Oncotarget 2013
Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo
H Fan, X Zhao, S Sun, M Luo, JL Guan
The Journal of biological chemistry 2012
Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis
JH Tsai, JL Donaher, DA Murphy, S Chau, J Yang
Cancer Cell 2012
Cancer Stem Cells
Z Yu, TG Pestell, MP Lisanti, RG Pestell
The International Journal of Biochemistry & Cell Biology 2012
Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity
ZQ Wu, T Brabletz, E Fearon, AL Willis, CY Hu, XY Li, SJ Weiss
Proceedings of the National Academy of Sciences 2012
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors
A Latifi, RB Luwor, M Bilandzic, S Nazaretian, K Stenvers, J Pyman, H Zhu, EW Thompson, MA Quinn, JK Findlay, N Ahmed
PloS one 2012
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
C Oliveras-Ferraros, B Corominas-Faja, S Cufí, A Vazquez-Martin, B Martin-Castillo, JM Iglesias, E López-Bonet, ÁG Martin, JA Menendez
Cell cycle (Georgetown, Tex.) 2012
Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression
X Xiang, ZB Deng, X Zhuang, S Ju, J Mu, H Jiang, L Zhang, J Yan, D Miller, HG Zhang
PloS one 2012
Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential
AV Salnikov, L Liu, M Platen, J Gladkich, O Salnikova, E Ryschich, J Mattern, G Moldenhauer, J Werner, P Schemmer, MW Büchler, I Herr, FH Sarkar
PloS one 2012
Dynamic interactions
S Seton-Rogers
Nature Reviews Cancer 2012
Cellular plasticity and metastatic potential.
BoneKEy Reports 2012
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 3 X users
Referenced in 4 patents
Highlighted by 1 platforms
Referenced by 1 Bluesky users
350 readers on Mendeley
See more details